MedTrace Logo

Effect of Chromium on Blood Sugar After Sacroiliac Joint Injection

NCT06709313 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-11-29

No results posted yet for this study

Summary

The aim of this study is to investigate whether oral chromium supplementation can decrease steroid-induced hyperglycemia in diabetic patients undergoing ultrasound-guided sacroiliac joint injections through a randomized controlled trial (RCT).

Conditions

Interventions

DRUG

Chromium

Participants in the experimental group will receive oral chromium supplementation, the dosage of which is determined based on previous studies(200 mcg daily) taking into account safety and efficacy considerations. The supplementation will commence for 45 days following the injection.

Sponsors & Collaborators

  • Fayoum University

    lead OTHER

Principal Investigators

  • Mohamed A Hamed, MD · Faculty of medicine, Fayoum university

  • Atef M Sayed, MD · Faculty of medicine, Fayoum university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-03
Primary Completion
2025-01-31
Completion
2025-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06709313 on ClinicalTrials.gov